Metformin Causes G1-Phase Arrest via Down-Regulation of MiR-221 and Enhances TRAIL Sensitivity through DR5 Up-Regulation in Pancreatic Cancer Cells
出版年份 2015 全文链接
标题
Metformin Causes G1-Phase Arrest via Down-Regulation of MiR-221 and Enhances TRAIL Sensitivity through DR5 Up-Regulation in Pancreatic Cancer Cells
作者
关键词
-
出版物
PLoS One
Volume 10, Issue 5, Pages e0125779
出版商
Public Library of Science (PLoS)
发表日期
2015-05-09
DOI
10.1371/journal.pone.0125779
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Metformin repositioning as antitumoral agent: selective antiproliferative effects in human glioblastoma stem cells, via inhibition of CLIC1-mediated ion current
- (2015) Marta Gritti et al. Oncotarget
- Smarter drugs emerging in pancreatic cancer therapy
- (2014) A. Kleger et al. ANNALS OF ONCOLOGY
- Cancer statistics, 2014
- (2014) Rebecca Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Metformin induces microRNA-34a to downregulate the Sirt1/Pgc-1α/Nrf2 pathway, leading to increased susceptibility of wild-type p53 cancer cells to oxidative stress and therapeutic agents
- (2014) Minh Truong Do et al. FREE RADICAL BIOLOGY AND MEDICINE
- Trail Resistance Induces Epithelial-Mesenchymal Transition and Enhances Invasiveness by Suppressing PTEN via miR-221 in Breast Cancer
- (2014) Haiji Wang et al. PLoS One
- Comparative Effectiveness and Safety of Medications for Type 2 Diabetes: An Update Including New Drugs and 2-Drug Combinations
- (2013) Wendy L. Bennett et al. ANNALS OF INTERNAL MEDICINE
- Elevation of miR-221 and -222 in the internal mammary arteries of diabetic subjects and normalization with metformin
- (2013) Chasity B. Coleman et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Metabolic roles of AMPK and metformin in cancer cells
- (2013) Yeon Kyung Choi et al. MOLECULES AND CELLS
- Gemcitabine Plus Erlotinib for Advanced Pancreatic Cancer: A Systematic Review with Meta-Analysis
- (2013) Zu-Yao Yang et al. PLoS One
- Phase I trial of exemestane in combination with metformin and rosiglitazone in nondiabetic obese postmenopausal women with hormone receptor–positive metastatic breast cancer
- (2012) Francisco J. Esteva et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Targeting microRNAs to modulate TRAIL-induced apoptosis of cancer cells
- (2012) T Lu et al. CANCER GENE THERAPY
- Metformin and Cancer Stem Cells: Old Drug, New Targets
- (2012) F. Bednar et al. Cancer Prevention Research
- Metformin suppresses growth of human head and neck squamous cell carcinoma via global inhibition of protein translation
- (2012) Arron Sikka et al. CELL CYCLE
- Metformin alters the expression profiles of microRNAs in human pancreatic cancer cells
- (2012) Weiguang Li et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Metformin Inhibits Cell Proliferation, Migration and Invasion by Attenuating CSC Function Mediated by Deregulating miRNAs in Pancreatic Cancer Cells
- (2011) B. Bao et al. Cancer Prevention Research
- FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer
- (2011) Thierry Conroy et al. NEW ENGLAND JOURNAL OF MEDICINE
- Metformin: A Therapeutic Opportunity in Breast Cancer
- (2010) A. M. Gonzalez-Angulo et al. CLINICAL CANCER RESEARCH
- A phase I study of temsirolimus and metformin in advanced solid tumours
- (2010) Mary J. MacKenzie et al. INVESTIGATIONAL NEW DRUGS
- Phase I Dose-Escalation Study of Recombinant Human Apo2L/TRAIL, a Dual Proapoptotic Receptor Agonist, in Patients With Advanced Cancer
- (2010) Roy S. Herbst et al. JOURNAL OF CLINICAL ONCOLOGY
- miR-221&222 Regulate TRAIL Resistance and Enhance Tumorigenicity through PTEN and TIMP3 Downregulation
- (2009) Michela Garofalo et al. CANCER CELL
- New Users of Metformin Are at Low Risk of Incident Cancer: A cohort study among people with type 2 diabetes
- (2009) G. Libby et al. DIABETES CARE
- Antisense Inhibition of microRNA-21 or -221 Arrests Cell Cycle, Induces Apoptosis, and Sensitizes the Effects of Gemcitabine in Pancreatic Adenocarcinoma
- (2009) Jong-Kook Park et al. PANCREAS
- MicroRNA signatures of TRAIL resistance in human non-small cell lung cancer
- (2008) M Garofalo et al. ONCOGENE
- The antidiabetic drug metformin exerts an antitumoral effect in vitro and in vivo through a decrease of cyclin D1 level
- (2008) I Ben Sahra et al. ONCOGENE
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started